5XCR
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xcr by Molmil](/molmil-images/mine/5xcr) | |
5XCX
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xcx by Molmil](/molmil-images/mine/5xcx) | Crystal structure of TS2/16 Fv-clasp fragment | Descriptor: | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID, GLYCEROL, PHOSPHATE ION, ... | Authors: | Arimori, T, Takagi, J. | Deposit date: | 2017-03-23 | Release date: | 2017-10-04 | Last modified: | 2017-10-18 | Method: | X-RAY DIFFRACTION (2.04 Å) | Cite: | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCS
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xcs by Molmil](/molmil-images/mine/5xcs) | Crystal structure of 12CA5 Fv-clasp fragment with its antigen peptide | Descriptor: | HA peptide, SULFATE ION, VH-SARAH(Y35C) chimera, ... | Authors: | Arimori, T, Takagi, J. | Deposit date: | 2017-03-23 | Release date: | 2017-10-04 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCU
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xcu by Molmil](/molmil-images/mine/5xcu) | Crystal structure of 12CA5 Fv-clasp fragment with its antigen peptide | Descriptor: | HA peptide, SULFATE ION, VH(S112C)-SARAH chimera,VH(S112C)-SARAH chimera, ... | Authors: | Arimori, T, Takagi, J. | Deposit date: | 2017-03-23 | Release date: | 2017-10-04 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (2.454 Å) | Cite: | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCQ
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xcq by Molmil](/molmil-images/mine/5xcq) | Crystal structure of P20.1 Fv-clasp fragment with its antigen peptide | Descriptor: | C8 peptide, SULFATE ION, VH-SARAH(Y35C)chimera, ... | Authors: | Arimori, T, Takagi, J. | Deposit date: | 2017-03-23 | Release date: | 2017-10-04 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (1.313 Å) | Cite: | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCV
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xcv by Molmil](/molmil-images/mine/5xcv) | Crystal structure of NZ-1 Fv-clasp fragment with its antigen peptide | Descriptor: | CALCIUM ION, PA14 peptide, VH(S112C)-SARAH chimera,VH(S112C)-SARAH chimera, ... | Authors: | Arimori, T, Takagi, J. | Deposit date: | 2017-03-23 | Release date: | 2017-10-11 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (2.143 Å) | Cite: | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|
5XCT
![Download](https://newweb-cs.pages.dev/newweb/media/icons/dl.png) ![Visualize](https://newweb-cs.pages.dev/newweb/media/icons/hoh_3d.png)
![BU of 5xct by Molmil](/molmil-images/mine/5xct) | Crystal structure of P20.1 Fv-clasp fragment with its antigen peptide | Descriptor: | C8 peptide, CHLORIDE ION, VH(S112C)-SARAH chimera, ... | Authors: | Arimori, T, Takagi, J. | Deposit date: | 2017-03-23 | Release date: | 2017-10-04 | Last modified: | 2023-11-22 | Method: | X-RAY DIFFRACTION (1.17 Å) | Cite: | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability Structure, 25, 2017
|
|